Fundies. English
Segment disclosures
Company overviewNATURES SUNSHINE PRODUCTS INC
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
100 dimension combinations 780 retained observations 13 reported periods Partial retained history
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Cardiovascular Products · Asia Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 12763000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 54555000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 15935000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 42468000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 12714000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 26533000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 13819000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 56266000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 14556000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 42155000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13625000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 27599000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 13974000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 57771000 | USD | 20250311 | Open filing evidence |
Operating Segments · Cardiovascular Products · Europe Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3223000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 10805000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2600000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 7804000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2639000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5204000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2565000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 9265000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2997000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 7712000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2296000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4715000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2419000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 9143000 | USD | 20250311 | Open filing evidence |
Operating Segments · Cardiovascular Products · Latin America And Other Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 455000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1614000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 394000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1217000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 390000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 823000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 433000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1726000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 448000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1331000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 401000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 883000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 482000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1718000 | USD | 20250311 | Open filing evidence |
Operating Segments · Cardiovascular Products · North America Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3900000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 14661000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 4036000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11449000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3717000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 7413000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 3696000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 14443000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3630000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 11371000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3757000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7741000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 3984000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 14959000 | USD | 20250311 | Open filing evidence |
Operating Segments · Digestive Products · Asia Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 12088000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 47673000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 13657000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 33825000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10526000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20168000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 9642000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 38958000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 10905000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 27201000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 7707000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16296000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 8589000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 36434000 | USD | 20250311 | Open filing evidence |
Operating Segments · Digestive Products · Europe Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 6871000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 24601000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5788000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 17790000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5630000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 12002000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 6372000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 22748000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3675000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 15535000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5947000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11860000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5913000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22111000 | USD | 20250311 | Open filing evidence |
Operating Segments · Digestive Products · Latin America And Other Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 2797000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 10290000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2514000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 7599000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2503000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5085000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2582000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 10713000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2846000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 8083000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2488000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5237000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2749000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 10693000 | USD | 20250311 | Open filing evidence |
Operating Segments · Digestive Products · North America Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 10743000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 41804000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9411000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 27596000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9251000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18185000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8934000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 39325000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 8583000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 26306000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8555000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 17723000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 9168000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 34628000 | USD | 20250311 | Open filing evidence |
Operating Segments · General Health Products · Asia Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 18409000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 83632000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 24817000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 63470000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 20402000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 38653000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 18251000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 81313000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 22572000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 57697000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 19131000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 35125000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 15994000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 69037000 | USD | 20250311 | Open filing evidence |
Operating Segments · General Health Products · Europe Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 11645000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 39794000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 9267000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 29370000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9607000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20103000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 10496000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 36631000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 9194000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 28530000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 9534000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 19336000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 9802000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 34709000 | USD | 20250311 | Open filing evidence |
Operating Segments · General Health Products · Latin America And Other Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 1830000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 6470000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1571000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4811000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1662000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3240000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1578000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6418000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1753000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4887000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1564000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3134000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1570000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6286000 | USD | 20250311 | Open filing evidence |
Operating Segments · General Health Products · North America Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 17186000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 62226000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 16231000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 47535000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 15705000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 31304000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 15599000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 59520000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 15259000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 46698000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 15032000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 31439000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 16407000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 63742000 | USD | 20250311 | Open filing evidence |
Operating Segments · Immunity Products · Asia Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3195000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 14438000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 4456000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11311000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3983000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 6855000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2872000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 12052000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 2504000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6437000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2249000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3933000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1684000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5420000 | USD | 20250311 | Open filing evidence |
Operating Segments · Immunity Products · Europe Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 2480000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 9148000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2046000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 6474000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1987000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4428000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2441000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 8454000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1685000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6223000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2203000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4538000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2335000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8222000 | USD | 20250311 | Open filing evidence |
Operating Segments · Immunity Products · Latin America And Other Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 516000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 1847000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 455000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 1424000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 451000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 969000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 518000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2416000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 589000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1906000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 594000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1317000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 723000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2703000 | USD | 20250311 | Open filing evidence |
Operating Segments · Immunity Products · North America Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3954000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 15385000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3778000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 11887000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3665000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8109000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4444000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 15802000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3690000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 11675000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3540000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7985000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4445000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 16124000 | USD | 20250311 | Open filing evidence |
Operating Segments · Personal Care Products · Asia Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 3439000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 10074000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 2365000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 5671000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2108000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3306000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1198000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 5032000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1175000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3511000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1044000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2336000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1292000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5586000 | USD | 20250311 | Open filing evidence |
Operating Segments · Personal Care Products · Europe Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 1427000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 5813000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1481000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4427000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1315000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2946000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1631000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 5397000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 765000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3178000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1145000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2413000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1268000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4977000 | USD | 20250311 | Open filing evidence |
Operating Segments · Personal Care Products · Latin America And Other Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 229000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 906000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 206000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 695000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 245000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 489000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 244000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 1133000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 309000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 854000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 270000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 545000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 275000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1262000 | USD | 20250311 | Open filing evidence |
Operating Segments · Personal Care Products · North America Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 1882000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 6474000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 1795000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 4907000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1637000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3112000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1475000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6241000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1512000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4665000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1581000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3153000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1572000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6476000 | USD | 20250311 | Open filing evidence |
Operating Segments · Weight Management Products · Asia Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 2289000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 11405000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 3495000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 9297000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2931000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5802000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 2871000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 14173000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3581000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 14496000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 6228000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 10915000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4687000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 27003000 | USD | 20250311 | Open filing evidence |
Operating Segments · Weight Management Products · Europe Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 749000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 2972000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 925000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2097000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 563000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1172000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 609000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 2342000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 1299000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2335000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 477000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1036000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 559000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1939000 | USD | 20250311 | Open filing evidence |
Operating Segments · Weight Management Products · Latin America And Other Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 164000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 496000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 143000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 368000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 117000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 225000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 108000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 478000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 131000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 369000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 85000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 238000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 153000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 502000 | USD | 20250311 | Open filing evidence |
Operating Segments · Weight Management Products · North America Segment
Consolidation Items · Product Or Service · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-01-01 – 2026-03-31 | 658000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 3061000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 973000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 2845000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1002000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1872000 | USD | 20250731 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 870000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3518000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 957000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3004000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1098000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2047000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 949000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3875000 | USD | 20250311 | Open filing evidence |
Operating Segments · Asia Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 52997000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 105180000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 52183000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 221777000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 64725000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 166042000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 52664000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 101317000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 48653000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 207794000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 55293000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 151497000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 49984000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 96204000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 46220000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 201251000 | USD | 20250311 | Open filing evidence |
Operating Segments · Europe Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 22694000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 49089000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 26395000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 93133000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 22107000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 67962000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 21741000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 45855000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 24114000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 84837000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 19615000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 63513000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 21602000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 43898000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 22296000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 81101000 | USD | 20250311 | Open filing evidence |
Operating Segments · Latin America And Other Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 5343000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 11334000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 5991000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 21623000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5283000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 16114000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5368000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 10831000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 5463000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 22884000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 6076000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 17430000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5402000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11354000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5952000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 23164000 | USD | 20250311 | Open filing evidence |
Operating Segments · North America Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 35951000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 74274000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 38323000 | USD | 20260507 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 143611000 | USD | 20260310 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 36224000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 106219000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 34977000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 69995000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 35018000 | USD | 20260507 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 138849000 | USD | 20260310 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 33631000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 103719000 | USD | 2025-11-06 · 22:11:13.000Z | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 33563000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 70088000 | USD | 20250731 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 36525000 | USD | 20250506 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 139804000 | USD | 20250311 | Open filing evidence |
Cardiovascular Products · Asia Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 14556000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 42155000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 13625000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 27599000 | USD | 20240808 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 14963000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 44698000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 14840000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 29735000 | USD | 20240808 | Open filing evidence |
Cardiovascular Products · Asia Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 12825000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 25588000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 12714000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 26533000 | USD | 20260806 | Open filing evidence |
Cardiovascular Products · Europe Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2997000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 7712000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2296000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4715000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2419000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 9143000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2264000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 7085000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2302000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4821000 | USD | 20240808 | Open filing evidence |
Cardiovascular Products · Europe Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2895000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 6118000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2639000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5204000 | USD | 20260806 | Open filing evidence |
Cardiovascular Products · Latin America And Other Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 448000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1331000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 401000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 883000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1718000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 392000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1291000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 433000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 899000 | USD | 20240808 | Open filing evidence |
Cardiovascular Products · Latin America And Other Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 398000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 853000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 390000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 823000 | USD | 20260806 | Open filing evidence |
Cardiovascular Products · North America Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 3630000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 11371000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3757000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7741000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 3984000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 14959000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3634000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 10983000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 3761000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 7349000 | USD | 20240808 | Open filing evidence |
Cardiovascular Products · North America Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:CardiovascularProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 3713000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 7613000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3717000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 7413000 | USD | 20260806 | Open filing evidence |
Digestive Products · Asia Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 10905000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 27201000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 7707000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 16296000 | USD | 20240808 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 9186000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 30172000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 11564000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 20986000 | USD | 20240808 | Open filing evidence |
Digestive Products · Asia Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 9601000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 21689000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 10526000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20168000 | USD | 20260806 | Open filing evidence |
Digestive Products · Europe Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 3675000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 15535000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5947000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11860000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5913000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 22111000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5087000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17156000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 6331000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 12069000 | USD | 20240808 | Open filing evidence |
Digestive Products · Europe Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 6507000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 13378000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 5630000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 12002000 | USD | 20260806 | Open filing evidence |
Digestive Products · Latin America And Other Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2846000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 8083000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2488000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 5237000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 10693000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2560000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8030000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2585000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 5470000 | USD | 20240808 | Open filing evidence |
Digestive Products · Latin America And Other Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2519000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 5316000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2503000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5085000 | USD | 20260806 | Open filing evidence |
Digestive Products · North America Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 8583000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 26306000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 8555000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 17723000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 9168000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 8577000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26069000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 8761000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 17492000 | USD | 20240808 | Open filing evidence |
Digestive Products · North America Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:DigestiveProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 10081000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 20824000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9251000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 18185000 | USD | 20260806 | Open filing evidence |
General Health Products · Asia Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 22572000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 57697000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 19131000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 35125000 | USD | 20240808 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 16937000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 48859000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 18158000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31922000 | USD | 20240808 | Open filing evidence |
General Health Products · Asia Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 21486000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 39895000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 20402000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 38653000 | USD | 20260806 | Open filing evidence |
General Health Products · Europe Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 9194000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 28530000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 9534000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 19336000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 34709000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 8034000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 25823000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 8615000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 17789000 | USD | 20240808 | Open filing evidence |
General Health Products · Europe Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 9589000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 21234000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9607000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 20103000 | USD | 20260806 | Open filing evidence |
General Health Products · Latin America And Other Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 1753000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4887000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1564000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3134000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6286000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1480000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4717000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1600000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3237000 | USD | 20240808 | Open filing evidence |
General Health Products · Latin America And Other Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1582000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 3412000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1662000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3240000 | USD | 20260806 | Open filing evidence |
General Health Products · North America Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 15259000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 46698000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 15032000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 31439000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 63742000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 16334000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 47725000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 15857000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 31390000 | USD | 20240808 | Open filing evidence |
General Health Products · North America Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 16242000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 33428000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 15705000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 31304000 | USD | 20260806 | Open filing evidence |
Immunity Products · Asia Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 2504000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6437000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2249000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3933000 | USD | 20240808 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1964000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3738000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1312000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 1774000 | USD | 20240808 | Open filing evidence |
Immunity Products · Asia Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 3079000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 6274000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3983000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 6855000 | USD | 20260806 | Open filing evidence |
Immunity Products · Europe Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 1685000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 6223000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2203000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 4538000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 2335000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 8222000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1563000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 5988000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2141000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 4425000 | USD | 20240808 | Open filing evidence |
Immunity Products · Europe Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1883000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4363000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1987000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 4428000 | USD | 20260806 | Open filing evidence |
Immunity Products · Latin America And Other Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 589000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 1906000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 594000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1317000 | USD | 20240808 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 611000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2023000 | USD | 20241107 | Open filing evidence |
Immunity Products · Latin America And Other Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 447000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 963000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 451000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 969000 | USD | 20260806 | Open filing evidence |
Immunity Products · North America Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 3690000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 11675000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 3540000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 7985000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 4445000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3641000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11693000 | USD | 20241107 | Open filing evidence |
Immunity Products · North America Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:ImmunityProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 3321000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 7275000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3665000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 8109000 | USD | 20260806 | Open filing evidence |
Personal Care Products · Asia Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 1175000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3511000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1044000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2336000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1292000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5586000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1376000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4159000 | USD | 20241107 | Open filing evidence |
Personal Care Products · Asia Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 3530000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 6969000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2108000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3306000 | USD | 20260806 | Open filing evidence |
Personal Care Products · Europe Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 765000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3178000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1145000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2413000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1268000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 4977000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1348000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3779000 | USD | 20241107 | Open filing evidence |
Personal Care Products · Europe Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1124000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 2551000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1315000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2946000 | USD | 20260806 | Open filing evidence |
Personal Care Products · Latin America And Other Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 309000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 854000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 270000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 545000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1262000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 284000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 976000 | USD | 20241107 | Open filing evidence |
Personal Care Products · Latin America And Other Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 223000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 452000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 245000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 489000 | USD | 20260806 | Open filing evidence |
Personal Care Products · North America Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 1512000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4665000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1581000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3153000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1572000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6476000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1720000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4818000 | USD | 20241107 | Open filing evidence |
Personal Care Products · North America Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:PersonalCareProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 1879000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 3761000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1637000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3112000 | USD | 20260806 | Open filing evidence |
Weight Management Products · Asia Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 3581000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 14496000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 6228000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 10915000 | USD | 20240808 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 7792000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 21812000 | USD | 20241107 | Open filing evidence |
Weight Management Products · Asia Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2476000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4765000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 2931000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 5802000 | USD | 20260806 | Open filing evidence |
Weight Management Products · Europe Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 1299000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2335000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 477000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1036000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 559000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 1939000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 473000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1579000 | USD | 20241107 | Open filing evidence |
Weight Management Products · Europe Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 696000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1445000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 563000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1172000 | USD | 20260806 | Open filing evidence |
Weight Management Products · Latin America And Other Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 131000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 369000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 85000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 238000 | USD | 20240808 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 502000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 96000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 401000 | USD | 20241107 | Open filing evidence |
Weight Management Products · Latin America And Other Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 174000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 338000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 117000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 225000 | USD | 20260806 | Open filing evidence |
Weight Management Products · North America Segment
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 957000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 3004000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 1098000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 2047000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 949000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 3875000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 886000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2810000 | USD | 20241107 | Open filing evidence |
Weight Management Products · North America Segment · Operating Segments
Product Or Service · Statement Business Segments · Consolidation Items
Source dimensions
srt:ProductOrServiceAxis=natr:WeightManagementProductsMember;us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 715000 | USD | 20260806 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 1373000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1002000 | USD | 20260806 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 1872000 | USD | 20260806 | Open filing evidence |
Asia Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 55293000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 151497000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 49984000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 96204000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 46220000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 201251000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 52218000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 153438000 | USD | 20241107 | Open filing evidence |
Asia Segment · Cardiovascular Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ProductOrServiceAxis=natr:CardiovascularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 13974000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 57771000 | USD | 20240312 | Open filing evidence |
Asia Segment · Digestive Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 8589000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 36434000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 9186000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 30172000 | USD | 20231107 | Open filing evidence |
Asia Segment · General Health Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 15994000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 69037000 | USD | 20240312 | Open filing evidence |
Asia Segment · Immunity Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 1684000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 5420000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1964000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 3738000 | USD | 20231107 | Open filing evidence |
Asia Segment · Personal Care Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 1376000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4159000 | USD | 20231107 | Open filing evidence |
Asia Segment · Weight Management Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:AsiaSegmentMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 4687000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 27003000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 7792000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 21812000 | USD | 20231107 | Open filing evidence |
Europe Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 19615000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 63513000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 21602000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 43898000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 22296000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 81101000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 18769000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 61410000 | USD | 20241107 | Open filing evidence |
Europe Segment · Digestive Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 5087000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17156000 | USD | 20231107 | Open filing evidence |
Europe Segment · General Health Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 9802000 | USD | 20240507 | Open filing evidence |
Europe Segment · Weight Management Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:EuropeSegmentMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 473000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1579000 | USD | 20231107 | Open filing evidence |
Latin America And Other Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 6076000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 17430000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5402000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 11354000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 5952000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 23164000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5423000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17438000 | USD | 20241107 | Open filing evidence |
Latin America And Other Segment · Cardiovascular Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ProductOrServiceAxis=natr:CardiovascularProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 482000 | USD | 20240507 | Open filing evidence |
Latin America And Other Segment · Digestive Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 2749000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2560000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 8030000 | USD | 20231107 | Open filing evidence |
Latin America And Other Segment · General Health Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 1570000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1480000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4717000 | USD | 20231107 | Open filing evidence |
Latin America And Other Segment · Immunity Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 723000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2703000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 611000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2023000 | USD | 20231107 | Open filing evidence |
Latin America And Other Segment · Personal Care Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 275000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 284000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 976000 | USD | 20231107 | Open filing evidence |
Latin America And Other Segment · Weight Management Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:LatinAmericaAndOtherSegmentMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 153000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 96000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 401000 | USD | 20231107 | Open filing evidence |
North America Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-07-01 – 2024-09-30 | 33631000 | USD | 20241107 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 103719000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 33563000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 70088000 | USD | 20240808 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 36525000 | USD | 20240507 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 139804000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 34792000 | USD | 20241107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 104098000 | USD | 20241107 | Open filing evidence |
North America Segment · Digestive Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ProductOrServiceAxis=natr:DigestiveProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 34628000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 8577000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 26069000 | USD | 20231107 | Open filing evidence |
North America Segment · General Health Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ProductOrServiceAxis=natr:GeneralHealthProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 16407000 | USD | 20240507 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 16334000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 47725000 | USD | 20231107 | Open filing evidence |
North America Segment · Immunity Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ProductOrServiceAxis=natr:ImmunityProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-12-31 | 16124000 | USD | 20240312 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 3641000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 11693000 | USD | 20231107 | Open filing evidence |
North America Segment · Personal Care Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ProductOrServiceAxis=natr:PersonalCareProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 1720000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4818000 | USD | 20231107 | Open filing evidence |
North America Segment · Weight Management Products
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=natr:NorthAmericaSegmentMember;srt:ProductOrServiceAxis=natr:WeightManagementProductsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 886000 | USD | 20231107 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 2810000 | USD | 20231107 | Open filing evidence |